Nu Skin Enterprises, Inc. (NYSE:NUS) has been given a consensus recommendation of “Hold” by the ten brokerages that are covering the company, MarketBeat.com reports. Two equities research analysts have rated the stock with a sell rating, three have given a hold rating and five have assigned a buy rating to the company. The average twelve-month price objective among analysts that have covered the stock in the last year is $62.25.

Several analysts have recently commented on the company. Zacks Investment Research upgraded Nu Skin Enterprises from a “hold” rating to a “buy” rating and set a $70.00 target price for the company in a research note on Wednesday, July 12th. Bank of America Corporation raised their price target on shares of Nu Skin Enterprises from $53.00 to $57.00 and gave the company an “underperform” rating in a research report on Monday, July 10th. Deutsche Bank AG raised their price target on shares of Nu Skin Enterprises from $63.00 to $66.00 and gave the company a “buy” rating in a research report on Wednesday, June 21st. Pivotal Research reissued a “buy” rating and set a $65.00 target price on shares of Nu Skin Enterprises in a research report on Thursday, May 4th. Finally, ValuEngine raised shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research report on Friday, June 2nd.

TRADEMARK VIOLATION NOTICE: “Nu Skin Enterprises, Inc. (NYSE:NUS) Receives Average Recommendation of “Hold” from Brokerages” was first published by American Banking News and is the sole property of of American Banking News. If you are reading this piece of content on another domain, it was illegally copied and reposted in violation of U.S. and international copyright & trademark legislation. The correct version of this piece of content can be viewed at https://www.americanbankingnews.com/2017/07/25/nu-skin-enterprises-inc-nysenus-receives-average-recommendation-of-hold-from-brokerages.html.

Shares of Nu Skin Enterprises (NUS) traded up 1.42% during midday trading on Tuesday, hitting $65.62. The company had a trading volume of 553,668 shares. Nu Skin Enterprises has a one year low of $46.35 and a one year high of $66.04. The stock’s 50-day moving average price is $61.39 and its 200-day moving average price is $55.35. The stock has a market capitalization of $3.47 billion, a price-to-earnings ratio of 21.78 and a beta of 1.31.

Nu Skin Enterprises (NYSE:NUS) last posted its quarterly earnings data on Wednesday, May 3rd. The company reported $0.51 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.50 by $0.01. Nu Skin Enterprises had a return on equity of 23.45% and a net margin of 7.48%. The business had revenue of $499.10 million during the quarter, compared to the consensus estimate of $493.65 million. During the same period in the prior year, the business posted $0.42 earnings per share. Nu Skin Enterprises’s quarterly revenue was up 5.8% on a year-over-year basis. Analysts predict that Nu Skin Enterprises will post $3.12 EPS for the current year.

In other Nu Skin Enterprises news, General Counsel D Matthew Dorny sold 8,000 shares of the company’s stock in a transaction dated Thursday, May 11th. The shares were sold at an average price of $58.32, for a total value of $466,560.00. Following the sale, the general counsel now owns 53,730 shares in the company, valued at $3,133,533.60. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Insiders have sold 24,250 shares of company stock worth $1,436,770 in the last quarter. 5.20% of the stock is owned by corporate insiders.

A number of large investors have recently made changes to their positions in NUS. Independent Portfolio Consultants Inc. boosted its stake in Nu Skin Enterprises by 1.7% in the first quarter. Independent Portfolio Consultants Inc. now owns 2,375 shares of the company’s stock worth $132,000 after buying an additional 40 shares during the last quarter. ProShare Advisors LLC bought a new position in shares of Nu Skin Enterprises during the first quarter worth $245,000. Profund Advisors LLC bought a new position in shares of Nu Skin Enterprises during the first quarter worth $384,000. Nationwide Fund Advisors increased its position in shares of Nu Skin Enterprises by 4.3% in the first quarter. Nationwide Fund Advisors now owns 84,011 shares of the company’s stock worth $4,666,000 after buying an additional 3,444 shares during the period. Finally, Retirement Systems of Alabama bought a new position in shares of Nu Skin Enterprises during the first quarter worth $3,543,000. Institutional investors and hedge funds own 85.58% of the company’s stock.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.

Analyst Recommendations for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises Inc. and related companies with MarketBeat.com's FREE daily email newsletter.